Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pleural Diseases × Fentanyl × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 24 Neoplasms 20 Cancer Pain 8 Colonic Neoplasms 7 Breakthrough Pain 6 Agnosia 6 Breast Neoplasms 5 Rectal Neoplasms 4 Prostatic Neoplasms 4 Lung Neoplasms 4 Chronic Pain 4 Urinary Bladder Neoplasms 3 Sarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Pain, Postoperative 3 Lymphoma, Follicular 3 Head and Neck Neoplasms 3 Breakthrough Cancer Pain 3 Waldenstrom Macroglobulinemia 2 Uterine Cervical Neoplasms 2 Thrombocythemia, Essential 2 Sezary Syndrome 2 Primary Myelofibrosis 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Polycythemia Vera 2 Pleural Effusion, Malignant 2 Pdgfra-Associated Chronic Eosinophilic Leukemia 2 Myeloproliferative Disorders 2 Mycosis Fungoides 2

Interventions

Trioxsalen 2 Photochemotherapy 2 Dihematoporphyrin Ether 2 1-phenyl-3,3-dimethyltriazene 2 Tyrosine Kinase Inhibitors 1 Thoracoscopy 1 Thoracic Surgery, Video-Assisted 1 Tea 1 Syndecan-1 1 Surgical Procedures, Operative 1 Phototherapy 1 Osteopontin 1 One-Lung Ventilation 1 Mesothelin 1 Hyaluronic Acid 1 Fentanyl 1 Deoxyribonucleases 1 Dasatinib 1 Clinical Laboratory Techniques 1 Chest Tubes 1 Anesthesia, General 1 Afatinib 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03973957 2019-06-04

TOPIC

The Cooper Health System

Phase NA Unknown

Pleural Diseases, Pleural Effusion, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡